Skip to main content

Table 1 Operationalization of measures for guideline-recommended metabolic management

From: Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation

Parameter

Thresholds

Management elements

Operationalization

Data source

Weight

BMI ≥30, weight gain >5%

Antipsychotic management

Switch to medication w/ lower propensity for weight gain

VA dataset

Lifestyle modification

Counseling on diet, exercise, and behavior modification within 30 days, OR

Chart review

Nutrition consult within 30 days, OR

VA dataset

‘MOVE!’ Program encounter(s) within 30 days

VA dataset

Medication

Orlistat prescription within 30 days

VA dataset

Glucose

Plasma glucose ≥200 or Hgb A1c ≥6.5

Antipsychotic management

Switch to medication with lower propensity for elevated glucose

VA dataset

Lifestyle modification

Counseling on diet, exercise, and behavior modification within 30 days, OR

Chart review

Nutrition consult within 30 days, OR

VA dataset

‘MOVE!’ Program encounter(s) within 30 days

VA dataset

Follow-up

Primary care/diabetes clinic visit within 30 days

VA dataset

Medication

Hypoglycemic agent within 30 days

VA dataset

Lipids

LDL ≥160

Antipsychotic management

Switch to medication w/ lower propensity for elevated lipids

VA dataset

Lifestyle modification

Counseling on diet, exercise, and behavior modification within 30 days, OR

Chart review

Nutrition consult within 30 days, OR

VA dataset

‘MOVE!’ Program encounter(s) within 30 days

VA dataset

Follow-up

Primary care/medicine visit within 30 days

VA dataset

Medication

Statin prescription within 30 days

VA dataset